SCOTUS overturn of Chevron doctrine opens a Pandora's box for biopharma industry, expert says

For the last 40 years, when federal legislation was ambiguous or left an administrative gap, courts were required to defer to the interpretation of federal agencies. This stipulation, called the Chevron deference, gave government organizations the ability to advance their regulatory priorities.